110 likes | 124 Views
Global Bronchodilator Drug Market was esteemed at US$40.623 billion out of 2019. The rising number of individuals experiencing COPD and asthma bolstered by the nearness of significant bronchodilator drug market players in the area is energizing the market development of bronchodilator sedates in North America.<br><br>For more information visit here: https://www.knowledge-sourcing.com/report/global-bronchodilator-drug-market<br>
E N D
Bronchodilator Drug Market Forecast From 2019 to 2024
DESCRIPTION As per the latest reports by Knowledge Sourcing Intelligence, The global market for bronchodilator drugs is increasing due to the rising incidence of various respiratory diseases worldwide. The increase in the prevalence of respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD) worldwide is growing the demand for bronchodilator drugs. The increasing air pollution due to rising industries and the increasing number of automobiles on the road around the world is the reason for growing respiratory problems. According to the WHO data, 7 million deaths were reported due to the joint effects of household (HAP) and ambient air pollution (AAP) in 2016 globally, with around 94 percent occurred in low and middle-income (LMI) countries. The growing global aging population is another driver of the global bronchodilator drug market. According to the World Bank Data, the percentage of population aged 65 and above increased from 7.49 in 2009 to 8.87 in the year 2018.
Key Questions Answered By The Report • What will be Bronchodilator Drug Marketfrom 2019 to 2024? • How are the major drivers and restraints affecting the Bronchodilator Drug Market? • growth and the opportunities which exist for key vendors? • Which segment and region will drive or lead the market growth and why? • A comprehensive analysis of competitive landscape and key market participant’s behavior • Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth
Segments Covered Under Bronchodilator Drug Market are : • By Disease • Asthma • Chronic Obstructive Pulmonary Disease (COPD) • Others • By Route of Administration • Oral • Injection • Inhaler
Geography • North America • USA • Canada • Mexico • South America • Brazil • Argentina • Others • Europe • Germany • France • United Kingdom • Spain • Others
Geography • Middle East and Africa • Saudi Arabia • Israel • UAE • Others • Asia Pacific • China • Japan • South Korea • India • Others
COMPANY PROFILES • F. Hoffmann-La Roche Ltd • Gilead Sciences, Inc. • GlaxoSmithKline plc. • Merck & Co., Inc. • Novartis AG • Verona Pharma plc • Pfizer Inc. • Abbott • AstraZeneca plc
TO ORDER OR REQUEST FOR A SAMPLE: Bronchodilator Drug Market– Forecasts from 2019 to 2024 Link : https://www.knowledge-sourcing.com/report/global-bronchodilator-drug-market Price: US$3,160 – Single User License US$4,550 – Multi User License US$6,950 – Enterprise License Payment: To pay by Credit Card, please, click “Add to Cart” button on product page and proceed with payment. For wire transfer, write to us at sales@knowledge-sourcing.com For any custom requirements or queries, please visit our website or call us: Website: www.knowledge-sourcing.com Phone: +1-850-250-1698
Contact Us Address Knowledge Sourcing Intelligence LLPSuite 406, BSI Business ParkH-140, Sector 63 Noida, U.P. - 201301India Phone: +1-850-250-1698 Email info@knowledge-sourcing.com Visit us : https://www.knowledge-sourcing.com
Follow Us: Press Releases and Blogs: Click Here…
THANK YOU